US 12036283
Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods
granted A61KA61K38/00A61K38/2086
Quick answer
US patent 12036283 (Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods) held by Nektar Therapeutics expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K38/00, A61K38/2086, A61K47/60, A61P